CClinicalTrials.gg
RecruitingNCT06462937SPARKUpdated Aug 20, 2026

A Digital Exercise Intervention in Patients With Spondyloarthritis

An interventional study of Exercise with supervision and Exercise without supervision in Spondyloarthritis and Exercise, sponsored by Diakonhjemmet Hospital. Recruiting at 1 site in Norway. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-20.

Sponsored by Diakonhjemmet Hospital · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
260
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This protocol describes a 6-month randomised, controlled exercise trial in patients with axial spondyloarthritis (axSpA) with re-randomization after 3-months. The primary outcome of the trial (disease activity) will be evaluated at 3-months. The exercise programme on trial comprises high intensity interval training (HIIT), muscular strength exercise and aerobic physical activity sessions of specified duration, frequency, and intensity. It also includes brief knowledge videos to empower the patient. The intervention is remotely delivered by the SPARK application with personalised follow-up including monitoring to ensure exercise progression and adherence to exercise intensity. The SPARK application is built on a platform delivered by ABEL Technologies (trademark) and is customised for patients with axSpA.

Read the detailed description

Main objectives: To assess if a digital personally tailored exercise program with remote follow-up can reduce disease activity measured by ankylosing spondylitis disease activity score (ASDAS) in patients with recently diagnosed axial spondyloarthritis (axSpA).

Main inclusion criteria Adults (> 18 years) with clinical diagnosis from a rheumatologist of axSpA within the last 2 years of inclusion also fulfilling the ankylosing spondylitis disease activity score (ASAS) classification criteria, who are biologic disease modifying anti-rheumatic drugs (bDMARD) naïve, and have an active disease (ASDAS ≥ 1.3)

Main exclusion criteria:

Active iridocyclitis, c-reactive protein (CRP) > 30, contraindication to high intensity interval training

Primary outcome Proportion of participants in ASDAS inactive (ASDAS \< 1.3) at 3 months

Number of participants: 260 (with an anticipated drop-out rate of 15%)

Study design: A two-arm multi-centre, clinical trial, randomization 1:1 to either digital exercise intervention with remote follow-up or usual care.

Intervention: Exercise delivered through an application and with personalised follow-up by a coach through remote sessions (the participant and SPARK-coach are not at the same physical location) weekly. The exercise is progressively tailored to the fitness level of each participant. The program consists of 5 session per week on 3 different days including: two sessions with HIIT, 2 sessions with strength exercise, and one session with an aerobic exercise at moderate intensity. Goal for HIIT is 10 minutes two times per week at 85-95% of maximal heart rate (20 minutes in total). The exercise will be performed at a location of the participants' choice and data will be logged by a sports watch.

Efficacy assessments: ASDAS disease activity measure (4 patient reported questions and measure of CRP), Bath ankylosing spondylitis disease activity index (BASDAI).

Physical measure: cardiorespiratory fitness, in a subset of participants direct cardiopulmonary testing, muscular strength tests.

Psychological measures: Warwick and Edinburgh mental wellbeing scale (WEMWBS), EuroQol (EQ5D).

Medication: use of bDMARDs, use of NSAID

Safety assessments General physical examination and vital signs, laboratory tests as a part of usual clinical care, record of adverse events and serious adverse events, magnetic resonance imaging (MRI).

02

Conditions studied

  • Spondyloarthritis
  • Exercise

Keywords

  • Remote
  • Digital
  • High intensity interval training
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • axSpA diagnosis within the last two years by a rheumatologist according to the ASAS criteria of 2009
  • active disease (ASDAS > 1.3)

Exclusion criteria

Exclusion Criteria:

  • Active uveitis.
  • CRP > 30.
  • Former or current use of bDMARDs.
  • Pregnancy or planned pregnancy within 6 months from inclusion.
  • Absolute and relative contradictions to high intensity exercise according to the American College of Sports Medicine (ACSM)
  • Other serious disease such as cancer.
  • Patients incapable to follow the protocol or the control set-up with remote monitoring.
04

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Care provider, Outcomes assessor)
Enrollment
260 participants (estimated)

Study arms

  • Experimental
    Exercise with personal supervision 0-3 months

    Exercise

    Behavioral: Exercise with supervision

  • No intervention
    Control 0-3 months

    Usual care

  • Experimental
    Exercise with personal supervision 3-6 months

    Exercise

    Behavioral: Exercise with supervision

  • Active comparator
    Exercise without personal supervision 3-6 months

    Exercise

    Behavioral: Exercise without supervision

Interventions

  • BehavioralExercise with supervision

    Remote exercise will be administered with digital supervision. The Exercise group will receive a personalised program with individual adaptations aiming to perform 3 exercise sessions per week including HIIT, strength exercise and moderate intensive aerobic exercise. Participants will consult their rheumatologist parallel to the SPARK trial.

  • BehavioralExercise without supervision

    Remote exercise will be administered without digital supervision. Participants will receive a standard exercise program fulfilling the exercise protocol requirements, the exercise program will progress. But there will be no direct contact between the participant and the coach. Participants will consult their rheumatologist parallel to the SPARK trial.

05

What researchers measure

Primary outcomes

  1. Disease activity 3 months

    Number of participants in ASDAS inactive (ASDAS \< 1.3) at 3 months

    Time frame: 3 months

Secondary outcomes

  1. Biologic disease modifying anti-rheumatic drugs 3 months

    Number of participants on biologic disease modifying anti-rheumatic drugs (bDMARD) at 3 months

    Time frame: 3 months

  2. Disease activity 6 months

    Number of participants in ankylosing spondylitis disease activity score (ASDAS) inactive (ASDAS \< 1.3) at 6 months

    Time frame: 6 months

  3. Proportion of participants using non-steroidal anti-inflammatory drugs

    Usage of non-steroidal anti-inflammatory drugs (NSAIDs)

    Time frame: 3 and 6 months

  4. Bath ankylosing spondylitis metrology index

    Physical function measured by Bath ankylosing spondylitis metrology index (BASMI). Range 0-10 where 0= no functional impairment 10=very significant impairment

    Time frame: 3 and 6 months

  5. Bath ankylosing spondylitis function index

    Physical function measured by Bath ankylosing spondylitis function index (BASFI). Scale range 0-10, where 0= no functional impairment 10=very significant impairment

    Time frame: 3 and 6 months

  6. Ankylosing spondylitis Performance Index

    Physical function measured by Ankylosing spondylitis Performance Index (ASPI). Continuous variable in units of minutes. The functional level is inversely proportional to the number of minutes.

    Time frame: 3 and 6 months

  7. Physical fitness

    Indirect exercise test on a tread-mill until exhaustion. Measured in oxygen uptake ml/min/kg.

    Time frame: 3 and 6 months

  8. Physiological effects of exercise on inflammation measured by CRP

    Effect of exercise on CRP

    Time frame: 3 and 6 months

  9. Physiological effects of exercise on blood pressure

    Effect of exercise on blood pressure

    Time frame: 3 and 6 months

  10. Physiological effects of exercise on weight

    Effect of exercise on weight in kg

    Time frame: 3 and 6 months

  11. Physiological effects of exercise on muscle mass

    Effect of exercise on body composition measured as percentage muscle mass

    Time frame: 3 and 6 months

  12. Physiological effects of exercise on adipose tissue

    Effect of exercise on body composition measured as percentage adipose tissue

    Time frame: 3 and 6 months

  13. Safety measures of exercise Spine

    Safety measures: MRI spine in a subset of participants at baseline and after 3 months of exercise. Level of inflammation scored by Canadian Spondyloarthritis Research Consortium score (SPARCC). High score represents more inflammation. The minimum score 0, max score 108

    Time frame: 3 and 6 months

  14. Safety measures of exercise Sacroiliac joints

    Safety measures: MRI sacroiliac joints in a subset of participants at baseline and after 3 months of exercise. Level of inflammation scored by Canadian Spondyloarthritis Research Consortium (SPARCC). High score represents more inflammation. The minimum score 0, max score 72

    Time frame: 3 and 6 months

  15. Effects of exercise on mental wellbeing

    Quality of life Warwick Edinburgh Mental Wellbeing Scale WEMWBS). Range 14-70. A higher score indicates greater mental well-being

    Time frame: 3 and 6 months

  16. Effects of exercise on quality of life

    Quality of life EQ5D. Range -0.59 to 1, where 1 is the best possible health state

    Time frame: 3 and 6 months

  17. Work presenteeism

    Health economy measures: work presenteeism expressed in percentage (%) measured by Work Productivity and Activity Impairment Questionnaire (WPAI)

    Time frame: 3 and 6 months

  18. Work absenteeism

    Health economy measures: work absenteeism expressed in percentage (%) measured by Work Productivity and Activity Impairment Questionnaire (WPAI)

    Time frame: 3 and 6 months

  19. Work impairment

    Health economy measures: work overall impairment expressed in percentage (%) measured by Work Productivity and Activity Impairment Questionnaire (WPAI)

    Time frame: 3 and 6 months

  20. Functional impairment

    Health economy measures: functional impairment expressed in percentage (%) measured by Work Productivity and Activity Impairment Questionnaire (WPAI)

    Time frame: 3 and 6 months

  21. Contact with the Healthcare services

    Health economy measures: Contact with the health care services. Self reported as number of visits to general practitioner, specialist healthcare and/or physiotherapist during past 3 months

    Time frame: 3 and 6 months

  22. Sleep quality

    Questionnaire on sleep quality: Pittsburgh Sleep Questionnaire. Global score ranges from 0 to 21 and higher scores indicate poorer sleep quality.

    Time frame: 3 and 6 months

  23. Physical activity level

    Physical activity level measured for one week at baseline, 3 months and 6 months by a movement sensor. (Actigraph). The score will be presented as Metabolic Equivalents. A high score represents more movement

    Time frame: Baseline, 3 and 6 months

  24. Adverse events

    We collect information of adverse events including any discomfort, muscle pain, joint pain, joint swallowing, dyspnoe, chest pain, ancle sprain, pain in a muscle group, pain in entheses, broken bones, infections. Participants report every 4 weeks through out the study, and SPARK coaches report for the participants at every follow-up.

    Time frame: 6 months

Other outcomes

  1. Adherence to exercise protocol

    Thorugh data collection with sports watch, blue tooth technology and the SPARK app we collect the pulse level during the aerobic exercises. Additionnally participants and physiotehrapist record exercises and work-load of the strentgh exercises directly in the SPARK app.

    Time frame: 6 months

06

Study locations

1 of 1 sites recruiting
  • Diakonhjemmet hospital
    Oslo, Norway
    • Birgitte Nellemann · Contact · 4747957020
    Recruiting
07

References and documents

Publications

  • Nellemann B, Fongen C, Dagfinrud H, Berg IJ, Kristianslund EK, Sexton J, Norden KR, Lillegraven S, Osteras N, Jorgensen TS, Carmona L, Sveaas SH, Provan SA. Remote personalised exercise in axial spondyloarthritis: the SPARK trial - protocol for a 6-month randomised controlled trial. BMJ Open. 2026 Mar 30;16(3):e112420. doi: 10.1136/bmjopen-2025-112420. PubMed 41916634 ↗

Individual participant data

Plan to share: No — Data will only be shared upon resonable request

08

Registry details

Key details

Study ID
NCT06462937
Lead sponsor
Diakonhjemmet Hospital
Responsible party
Sponsor
First posted
Jun 17, 2024
Start date
Jul 1, 2024
Primary completion
Aug 1, 2027 (estimated)
Completion
Aug 1, 2030 (estimated)
Last update
Aug 20, 2026

Study contacts

Sella A Provan, Professor
Contact
SellaProvan@gmail.com
4791582581
Birgitte Nellemann, PhD
Contact
birgittenellemann@gmail.com
4747957020

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion